Prognosis – Clinical Value of Diagnostics https://clinicalvalue.com Mon, 19 Jun 2023 03:34:59 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.2 https://i0.wp.com/clinicalvalue.com/wp-content/uploads/2023/01/apple-touch-icon.png?fit=32%2C32&ssl=1 Prognosis – Clinical Value of Diagnostics https://clinicalvalue.com 32 32 225041835 The prognostic values of serum markers in hepatocellular carcinoma after invasive therapies based on real-world data https://clinicalvalue.com/the-prognostic-values-of-serum-markers-in-hepatocellular-carcinoma-after-invasive-therapies-based-on-real-world-data/ Mon, 19 Jun 2023 03:34:59 +0000 https://clinicalvalue.com/?p=6885 The purpose of this study is to evaluate the prognostic values of serum markers in HCC, with retrospective data.

Li B, Liu A, Wen Y, Yang G, Zhao J, Li X, Mao Y, Li B...

The post The prognostic values of serum markers in hepatocellular carcinoma after invasive therapies based on real-world data appeared first on Clinical Value of Diagnostics.

]]>

Quick Summary

Hepatocellular carcinoma (HCC) is one of the most common malignancies with poor prognosis, and the mortality rate remains high. More than 70% of HCC patients have recurrence within 5 years after treatment. The purpose of this study is to evaluate the prognostic values of serum markers with retrospective data.

 

Real‐world data (RWD) was applied to analyze the prognostic values of six serum markers for HCC patients after treatment, including α‐fetoprotein (AFP), α‐fetoprotein‐L3 (AFP‐L3), Golgi protein73 (GP73), alanine aminotransferase (ALT), albumin (ALB), and total bilirubin (TBil). A total of 268 cases were enrolled to analyze recurrence‐free survival (RFS), and 104 cases were used to analyze overall survival (OS).

Access the full publication

The post The prognostic values of serum markers in hepatocellular carcinoma after invasive therapies based on real-world data appeared first on Clinical Value of Diagnostics.

]]> 6885